A Morand

915 total citations
28 papers, 706 citations indexed

About

A Morand is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, A Morand has authored 28 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Medicine, 17 papers in Pharmacology and 12 papers in Molecular Biology. Recurrent topics in A Morand's work include Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Microbial Natural Products and Biosynthesis (6 papers). A Morand is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Microbial Natural Products and Biosynthesis (6 papers). A Morand collaborates with scholars based in France, Luxembourg and Spain. A Morand's co-authors include Roger Labia, D. Sirot, J. Sirot, R Cluzel, Patrice Courvalin, Arlette Darfeuille–Michaud, A Petit, Kiran Tiwari, Jean Péduzzi and Guillaume Arlet and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A Morand

28 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Morand France 13 628 266 198 181 153 28 706
El Bachir Chaibi France 10 637 1.0× 179 0.7× 205 1.0× 250 1.4× 124 0.8× 12 718
Venus Tolün Türkiye 4 819 1.3× 218 0.8× 429 2.2× 161 0.9× 131 0.9× 5 865
Patrick Plésiat France 13 685 1.1× 214 0.8× 200 1.0× 333 1.8× 122 0.8× 17 864
Jan Walther‐Rasmussen Denmark 11 807 1.3× 226 0.8× 395 2.0× 227 1.3× 122 0.8× 13 890
Herin Oh Sweden 6 416 0.7× 136 0.5× 145 0.7× 162 0.9× 87 0.6× 6 550
Alexandros Ikonomidis Greece 16 661 1.1× 173 0.7× 284 1.4× 243 1.3× 96 0.6× 23 762
Catherine Llanes France 11 686 1.1× 191 0.7× 232 1.2× 426 2.4× 103 0.7× 12 875
Jessica A. O’Hara United States 8 579 0.9× 201 0.8× 216 1.1× 148 0.8× 144 0.9× 10 650
Estelle Marcon France 11 508 0.8× 116 0.4× 237 1.2× 162 0.9× 186 1.2× 11 689
Tamara Bergerová Czechia 13 584 0.9× 212 0.8× 262 1.3× 122 0.7× 230 1.5× 19 818

Countries citing papers authored by A Morand

Since Specialization
Citations

This map shows the geographic impact of A Morand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Morand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Morand more than expected).

Fields of papers citing papers by A Morand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Morand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Morand. The network helps show where A Morand may publish in the future.

Co-authorship network of co-authors of A Morand

This figure shows the co-authorship network connecting the top 25 collaborators of A Morand. A scholar is included among the top collaborators of A Morand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Morand. A Morand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morand, A, et al.. (2017). Pseudomonas aeruginosa en dermatologie. Annales de Dermatologie et de Vénéréologie. 144(11). 666–675. 19 indexed citations
2.
Morand, A, et al.. (1996). Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrobial Agents and Chemotherapy. 40(4). 1027–1029. 24 indexed citations
3.
Thabaut, A, M Meyran, Luc Sofer, A Morand, & Roger Labia. (1994). Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis.. PubMed. 20(2). 49–54. 8 indexed citations
4.
Labia, Roger & A Morand. (1994). Interaction of cefdinir with beta-lactamases.. PubMed. 20(2). 43–8. 11 indexed citations
5.
Labia, Roger, A Thabaut, A Morand, et al.. (1989). The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.. PubMed. 15(11-12). 535–40. 2 indexed citations
6.
Labia, Roger, et al.. (1989). Interactions of meropenera, with  -lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins. Journal of Antimicrobial Chemotherapy. 24(suppl A). 219–223. 18 indexed citations
7.
Labia, Roger, Michel Barthélémy, Jean Péduzzi, et al.. (1989). Proprietes des nouvelles beta-lactamases plasmidiques actives sur les cephalosporines de troisieme generation. position dans la classe a des beta-lactamases. Médecine et Maladies Infectieuses. 19. 27–36. 2 indexed citations
8.
Labia, Roger, A Morand, Kiran Tiwari, et al.. (1988). Interactions of New Plasmid-Mediated  -Lactamases with Third-Generation Cephalosporins. Clinical Infectious Diseases. 10(4). 885–891. 48 indexed citations
9.
Labia, Roger, et al.. (1988). Kinetic properties of two plasmid-mediated β-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins. Journal of Antimicrobial Chemotherapy. 21(3). 301–307. 25 indexed citations
10.
Sirot, D., Roger Labia, A Petit, et al.. (1988). Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy. 32(11). 1660–1665. 35 indexed citations
11.
Labia, Roger, Michel Barthélémy, Jean Péduzzi, A Morand, & Kiran Tiwari. (1988). [Behavior of ceftazidime in regard to different classes of beta-lactamases. The situation in 1988].. PubMed. 17(37). 1890–4. 1 indexed citations
12.
Sirot, D., J. Sirot, Roger Labia, et al.. (1987). Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. Journal of Antimicrobial Chemotherapy. 20(3). 323–334. 294 indexed citations
13.
Labia, Roger, et al.. (1986). Bêtalactamases de Klebsiella oxytoca: étude de leur action sur les céphalosporines de troisième génération.. Pathologie Biologie. 34. 21 indexed citations
14.
Labia, Roger, et al.. (1986). ß-Lactamase stability of imipenem. Journal of Antimicrobial Chemotherapy. 18(Supplement_E). 1–8. 16 indexed citations
15.
Labia, Roger, et al.. (1986). Sulbactam: Biochemical Factors Involved in Its Synergy with Ampicillin. Clinical Infectious Diseases. 8(Supplement_5). S496–S502. 46 indexed citations
16.
Labia, Roger, A Morand, & Jean Péduzzi. (1986). Timentin and  -lactamases. Journal of Antimicrobial Chemotherapy. 17(suppl C). 17–26. 13 indexed citations
17.
Labia, Roger, et al.. (1986). [Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins].. PubMed. 34(5 Pt 2). 611–5. 24 indexed citations
18.
Labia, Roger, A Morand, & A Kazmierczak. (1984). The action of  -lactamases on desacetyl-cefotaxime and cefotaxime. Journal of Antimicrobial Chemotherapy. 14(suppl B). 45–51. 7 indexed citations
19.
Labia, Roger, et al.. (1983). Affinité de la N-formimidoyl-thiénamycine (MK-0787) pour les bêta-lactamases, étude par une méthode statistique: Analyse des correspondances. Annales de l Institut Pasteur Microbiologie. 134(1). 29–38. 4 indexed citations
20.
Labia, Roger, A Morand, & Jean Péduzzi. (1983). Cefotetan and  -lactamases: II. An unusual property: the inactivation of some  -lactamases by cefotetan. Journal of Antimicrobial Chemotherapy. 11(suppl A). 153–157. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by El Bachir Chaibi Breakdown of academic impact, for papers by Venus Tolün Breakdown of academic impact, for papers by Patrick Plésiat Breakdown of academic impact, for papers by Jan Walther‐Rasmussen Breakdown of academic impact, for papers by Herin Oh Breakdown of academic impact, for papers by Alexandros Ikonomidis Breakdown of academic impact, for papers by Catherine Llanes Breakdown of academic impact, for papers by Jessica A. O’Hara Breakdown of academic impact, for papers by Estelle Marcon Breakdown of academic impact, for papers by Tamara Bergerová
Rankless by CCL
2026